Interleukin-2 Receptor Blocking Antibody [EPC]

7783 reported adverse events

Drugs of this class: BASILIXIMAB

These side effects are most commonly reported by patients taking drugs of the Interleukin-2 Receptor Blocking Antibody [EPC] class:

# Side effect Count
0 CYTOMEGALOVIRUS INFECTION 646
1 KIDNEY TRANSPLANT REJECTION 613
2 TRANSPLANT REJECTION 529
3 PYREXIA 515
4 BLOOD CREATININE INCREASED 434
5 DIARRHOEA 419
6 PRODUCT USE IN UNAPPROVED INDICATION 412
7 OFF LABEL USE 372
8 DRUG INEFFECTIVE 348
9 RENAL IMPAIRMENT 332
See all common reactions for Interleukin-2 Receptor Blocking Antibody [EPC]

Drugs of the Interleukin-2 Receptor Blocking Antibody [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VENTRICULAR REMODELLING 23 0.5349
1 DIABETIC MACROANGIOPATHY 15 0.5172
2 PASSENGER LYMPHOCYTE SYNDROME 13 0.3611
3 DELAYED GRAFT FUNCTION 142 0.2996
4 INTESTINE TRANSPLANT REJECTION 19 0.2714
5 RENAL GRAFT LOSS 20 0.2469
6 MALACOPLAKIA 21 0.2188
7 COMPLICATIONS OF TRANSPLANTED LUNG 40 0.2186
8 DONOR SPECIFIC ANTIBODY PRESENT 16 0.2162
9 ARTERITIS INFECTIVE 8 0.2051
See all enriched reactions for Interleukin-2 Receptor Blocking Antibody [EPC]